SQLite Web: event_store.db

Update row 46545 in events

seq

Primary key. INTEGER

id

TEXT NOT NULL

kind

TEXT NOT NULL

ts

TEXT NOT NULL

actor

TEXT

subject_entity_ids

TEXT

payload

{"created_at":"2026-04-15T02:18:53.247056+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:eec0781b19257d66","evidence_event_ids":["evt_e081ebea99ba"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1799191/0001950047-26-003442.txt","as_of":"2026-04-15T02:18:53.247056+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1799191/0001950047-26-003442.txt","company":"Oncology Institute, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1799191/0001950047-26-003442.txt","article_chars":1806,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_12c2fda943d1d020","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1799191/0001950047-26-003442.txt","content_type":"text/plain","enriched_at":"2026-04-15T05:17:08.538984+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1799191/0001950047-26-003442.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1799191/0001950047-26-003442.txt","source_event_id":"evt_e081ebea99ba","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"144","fp":"dd40fd014d92e6d7","kind":"sec_filing","published_at":"20260414","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-14","2026-04-15T02:18:53.247056+00:00","2020-01-08","2023-05-17","2024-06-14","2025-12-16","2023-05-17","2024-06-14"],"entities":[{"asset_class":"equity","name":"Oncology Institute, Inc.","relevance":"high","symbol":"TOIIW","type":"issuer"},{"asset_class":"person","name":"Mohit Kaushal","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"broker","name":"Morgan Stanley Smith Barney LLC","relevance":"medium","symbol":"","type":"broker"}],"event_type":"listing","information_gaps":["The cleaned text does not clearly specify the exact number of shares to be sold (fields appear but are not labeled in the provided text).","The filing\u2019s stated sale price, aggregate amount, and whether sales are planned over a specific period are not explicitly extractable from the provided text.","No explicit statement is provided about what changed versus a prior known state (no prior filing details were included in the signal)."],"key_facts":["SEC accession number: 0001950047-26-003442.","Form type: 144.","Filed as of date and date as of change: 2026-04-14.","Subject company: Oncology Institute, Inc. (CIK 0001799191).","Former company name: DFP Healthcare Acquisitions Corp. (name change date: 2020-01-08).","Reporting owner: Mohit Kaushal (Director).","The securities to be sold were acquired upon vesting of restricted stock units during the period of 5/17/2023 through 6/14/2024.","Business address: 18000 Studebaker Rd, Suite 800, Cerritos, CA 90703.","Broker listed: Morgan Stanley Smith Barney LLC, 1 New York Plaza, 8th Floor, New York, NY 10004."],"numeric_claims":[{"label":"EIN","value":"843562323"},{"label":"SEC file number","value":"001-39248"},{"label":"Brokerage/financial services number (as shown)","value":"95719"},{"label":"Quantity/number field shown (as shown)","value":"315872.70"},{"label":"Another numeric field shown (as shown)","value":"98839144"}],"primary_claim":"A Form 144 was filed on 2026-04-14 by Oncology Institute, Inc. for securities to be sold that were acquired upon vesting of restricted stock units during 5/17/2023 through 6/14/2024.","relevance_score":0.55,"sentiment":"neutral","source_quality":"medium","summary":"Oncology Institute, Inc. filed a Form 144 on 2026-04-14 for the sale of shares acquired via vesting of restricted stock units. The filing lists Mohit Kaushal (Director) as the reporting owner and indicates the securities were acquired during 5/17/2023 through 6/14/2024.","topics":["SEC Form 144","insider sale","restricted stock units vesting","Oncology Institute, Inc."]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 144 \u00b7 Oncology Institute, Inc. \u00b7 Filed 20260414","ticker":"TOIIW","tickers":["TOIIW"],"title":"TOIIW filed 144","url":"https://www.sec.gov/Archives/edgar/data/1799191/0001950047-26-003442.txt"}}

TEXT NOT NULL

source_ref

TEXT

confidence

REAL (default 0.0

dedupe_key

TEXT

episode_id

TEXT

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

Cancel